| Literature DB >> 35215883 |
Le Kang1, Abdul Wahaab2, Kun Shi2, Bahar E Mustafa3, Yan Zhang2,4, Junjie Zhang2, Zongjie Li2, Yafeng Qiu2, Beibei Li2, Ke Liu2, Donghua Shao2, Zhiyong Ma2, Dengke Zhong1, Jianchao Wei2.
Abstract
Porcine Circovirus 2 (PCV2) is a crucial swine pathogen and considered a primary causative agent of porcine circovirus-associated diseases (PCVADs), posing a serious economic threat to the swine industry across globe. The world's biggest agricultural conglomerates have teamed up to create giant commercial pig farms across Shanghai due to the proximity of this region to more affluent lean-pork markets. Since its discovery, PCV2 has displayed extraordinary genetic diversity, and its genome is swiftly evolving through a series of mutations and recombinations. However, limited information on epidemiology, molecular characteristics, vaccine cross-protection, and the co-infection rate of PCV2 with other lethal swine diseases can adversely impact the pig production in the region. To investigate the molecular epidemic characteristics and genetic evolution of PCV2, pigs with doubtful symptoms of PCVADs were sampled from various commercial pig farms with a history of PWMS and/or PDNS across Shanghai from 2014 to 2018. Our results revealed the coexistence of multiple PCV2 genotypes (PCV2b, PCV2e, and PCV2d) among Shanghai pig herds and dominance of PCV2d among them. We also found critical amino acid substitutions in epitope regions of important capsid proteins in PCV2 isolates involved in viral replication and host immune escape. Spotted mutations may favor the prevalence and survival of various PCV2 genotypes despite availability of commercial vaccines. This study also provides insight into the co-infection status of PCV2 with major lethal swine viral diseases such as PPV and PPRSV. Collectively, these investigations will contribute to understanding the molecular epidemiology and evolution of PCV2 across the region.Entities:
Keywords: Porcine Circovirus type 2; antigenic epitope; co-infection; genetic evolution; molecular epidemiology; polygenetic analysis
Mesh:
Substances:
Year: 2022 PMID: 35215883 PMCID: PMC8879946 DOI: 10.3390/v14020289
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Primer sequence used in study for virus screening through PCR.
| Primer Pairs | Primer Sequence | Amplified Length | Annealing Temperature | Virus Type |
|---|---|---|---|---|
| ORF5-F | 5′-AGGTGGGCAACTGTTTTAGC-3′ | 697 bp | 53.5 °C | PRRSV |
| ORF5-R | 5′-TTTGTGGAGCCGTGCTATCA-3′ | |||
| VP2-F | 5′-CACGCATCAAGACTCATA-3′ | 472 bp | 48.0 °C | PPV |
| VP2-R | 5′-TTGGTGGATTTAGGTTTC-3′ | |||
| PCV-F | 5′-CCGCGGGCTGGCTGAACTT-3′ | 1154 bp | 58.0 °C | PCV2 |
| PCV-R | 5′-ACCCCCGCCACCGCTACC-3′ |
Positive rate of PCV2 and its co-infection status with PRRSV and PPV from samples collected from various pig farms (Shanghai, China) between 2014 and 2018.
| Samples’ ID | Farm/Area | Herd | Positive Samples/Total Samples | PCV2 Positive Rate (%) | PCV2 + PRRSV | PCV2 + PPV | Farm |
|---|---|---|---|---|---|---|---|
| SH150127-1 | Fengxian | >500 | 6/10 | 60.0% | 0/6 | 6/6 | Yes |
| SH140624-5 | Pudong | >3000 | 13/21 | 61.9% | 0/13 | 13/13 | Yes |
| SH140718-1 | Pudong | >5000 | 10/15 | 66.7% | 0/10 | 10/10 | Yes |
| SH140704-1 | Jiading | >2000 | 16/27 | 59.3% | 0/16 | 16/16 | Yes |
| SH140704-3 | Jiading | >2000 | 9/15 | 60.0% | 0/9 | 9/9 | Yes |
| SH140804-1 | Fengxian | >2000 | 16/31 | 51.6% | 0/31 | 16/31 | Yes |
| SH140804-3 | Chongmei | >2000 | 13/20 | 65.0% | 0/13 | 13/13 | Yes |
| SH140625-2 | Pudong | >2000 | 4/7 | 57.1% | 4/4 | 4/4 | Yes |
| SH140625-1 | Fengxian | >500 | 4/8 | 50.0% | 2/4 | 4/4 | No |
| SH140625-3 | Chongmei | >2000 | 7/12 | 58.3% | 7/7 | 0/7 | Yes |
| SH1601 | Pudong | >2000 | 8/15 | 53.3% | 6/8 | 8/8 | Yes |
| SH1701 | Jiading | >2000 | 6/13 | 46.2% | 3/6 | 6/6 | Yes |
| SH1801 | Chongmei | >2000 | 3/5 | 60.0% | 3/3 | 3/3 | Yes |
Figure 1Alignment of capsid protein sequences of thirteen PCV2 isolates: (A,B); The grey highlighted area represents antibody recognition domains as described by Trible et al. (2011) [45]. The red solid line boxes show motifs of PCV2 determined by Cheung et al. (2007) and Cheung et al. (2009) [5,43]. The dashed green line represents the location of the immunodominant decoy epitope, which shows reactivity of PCV2 infected pigs’ serum rather than vaccinated pigs’ serum as reported by Trible et al. (2011) and Trible and Rowland et al. (2012) [45,48]. The new PCV2 isolates identified in this study are labeled with red circles, the reference PCV2 clades are represented with blue triangles, and PCV2 available vaccine strains are indicated with the green diamonds.
Figure 2Critical amino acid substitutions in ORF2 of various PCV2 genotypes, i.e., PCV2a, PCV2b, PCV2e, and PCV2d.
Figure 3Phylogenetic analysis: phylogenetic tree was constructed by neighbor-joining (NJ) method for newly isolated 13 ORF2 sequences of PCV2 using MEGA5.0 software. Bootstrap values were calculated on 1000 replicates. The reference sequences of PCV2 clades are indicated with blue triangles. The new PCV2 isolates identified in this study are labeled with red circles and PCV2 available vaccine strains are indicated with green diamonds.
Summary of PCV2 (Cap gene) isolates from Shanghai pig farms during this study and their GenBank accession numbers.
| Samples’ ID | Accession Number (GenBank) | Year | PCV2 Genotype | History of Disease | ORF2 Size (bp) | Tissues |
|---|---|---|---|---|---|---|
| SH150127-1 | KR058359 | 2015 | 2d | PMWS/PNDS | 705 | Lung, spleen, lymph node |
| SH140624-5 | KR058354 | 2014 | 2d | PMWS/PNDS | 705 | Lung, spleen, lymph nodes |
| SH140718-1 | KR058358 | 2014 | 2d | PMWS/PNDS | 705 | Inguinal lymph nodes |
| SH140704-1 | KR052145 | 2014 | 2d | PMWS/PNDS | 705 | Lung, spleen, lymph nodes |
| SH140704-3 | KR052146 | 2014 | 2d | No signs | 705 | Lung, spleen, lymph nodes |
| SH140804-1 | KR058352 | 2014 | 2d | PMWS/PNDS | 705 | Inguinal lymph nodes |
| SH140804-3 | KR058353 | 2014 | 2d | PMWS/PNDS | 705 | Inguinal lymph nodes |
| SH140625-2 | KR058356 | 2014 | 2d | PMWS/PNDS | 705 | Lung, spleen, lymph nodes |
| SH140625-1 | KR058355 | 2014 | 2b | PMWS/PNDS | 702 | Inguinal lymph nodes |
| SH140625-3 | KR058357 | 2014 | 2e | No signs | 702 | Inguinal lymph nodes |
| SH1601 | OM032620 | 2016 | 2d | PMWS/PNDS | 705 | Lung, spleen, lymph nodes |
| SH1701 | OM032621 | 2017 | 2d | PMWS/PNDS | 705 | Lung, spleen, lymph nodes |
| SH1801 | OM032622 | 2018 | 2d | PMWS/PNDS | 705 | Lung, spleen, lymph nodes |